These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7974349

  • 1. Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries.
    Piétu G, Ribba AS, Chérel G, Siguret V, Obert B, Rouault C, Ginsburg D, Meyer D.
    Thromb Haemost; 1994 Jun; 71(6):788-92. PubMed ID: 7974349
    [Abstract] [Full Text] [Related]

  • 2. Fine mapping of monoclonal antibody epitopes on human von Willebrand factor using a recombinant peptide library.
    Ginsburg D, Bockenstedt PL, Allen EA, Fox DA, Foster PA, Ruggeri ZM, Zimmerman TS, Montgomery RR, Bahou WF, Johnson TA.
    Thromb Haemost; 1992 Jan 23; 67(1):166-71. PubMed ID: 1377414
    [Abstract] [Full Text] [Related]

  • 3. Identification of novel peptide antagonists for von Willebrand factor binding to the platelet glycoprotein Ib receptor from a phage epitope library.
    South V, Searfoss GH, French S, Cheadle C, Murray E, Howk R, Jaye M, Ricca GA.
    Thromb Haemost; 1995 Jan 23; 73(1):144-50. PubMed ID: 7537918
    [Abstract] [Full Text] [Related]

  • 4. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
    Tout H, Obert B, Houllier A, Fressinaud E, Rothschild C, Meyer D, Girma JP.
    Thromb Haemost; 2000 Feb 23; 83(2):274-81. PubMed ID: 10739386
    [Abstract] [Full Text] [Related]

  • 5. Epitope mapping by cDNA expression of a monoclonal antibody which inhibits the binding of von Willebrand factor to platelet glycoprotein IIb/IIIa.
    Piétu G, Ribba AS, Chérel G, Meyer D.
    Biochem J; 1992 Jun 15; 284 ( Pt 3)(Pt 3):711-5. PubMed ID: 1377911
    [Abstract] [Full Text] [Related]

  • 6. Adhesive domains in the collagen III fragment alpha1(III)CB4 that support alpha2beta1- and von Willebrand factor-mediated platelet adhesion under flow conditions.
    Verkleij MW, IJsseldijk MJ, Heijnen-Snyder GJ, Huizinga EG, Morton LF, Knight CG, Sixma JJ, de Groot PG, Barnes MJ.
    Thromb Haemost; 1999 Sep 15; 82(3):1137-44. PubMed ID: 10494778
    [Abstract] [Full Text] [Related]

  • 7. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I, Arnout J, Deckmyn H, Peerlinck K, Vermylen J.
    J Clin Invest; 1993 Jan 15; 91(1):273-82. PubMed ID: 8423224
    [Abstract] [Full Text] [Related]

  • 8. Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domain.
    Shibata M, Shima M, Fujimura Y, Takahashi Y, Nakai H, Sakurai Y, Asatani M, Nomura A, Take H, Giddings JC, Yoshioka A.
    Thromb Haemost; 1999 May 15; 81(5):793-8. PubMed ID: 10365755
    [Abstract] [Full Text] [Related]

  • 9. Molecular genetics of von Willebrand disease.
    Mazurier C, Ribba AS, Gaucher C, Meyer D.
    Ann Genet; 1998 May 15; 41(1):34-43. PubMed ID: 9599650
    [Abstract] [Full Text] [Related]

  • 10. Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domain.
    Jorieux S, Gaucher C, Piétu G, Chérel G, Meyer D, Mazurier C.
    Br J Haematol; 1994 May 15; 87(1):113-8. PubMed ID: 7524613
    [Abstract] [Full Text] [Related]

  • 11. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium.
    Weiss HJ, Hoffmann T, Yoshioka A, Ruggeri ZM.
    J Lab Clin Med; 1993 Sep 15; 122(3):324-32. PubMed ID: 8409708
    [Abstract] [Full Text] [Related]

  • 12. Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.
    Girma JP, Kalafatis M, Piétu G, Lavergne JM, Chopek MW, Edgington TS, Meyer D.
    Blood; 1986 May 15; 67(5):1356-66. PubMed ID: 3008890
    [Abstract] [Full Text] [Related]

  • 13. Localization within the 106 N-terminal amino acids of von Willebrand factor (vWF) of the epitope corresponding to a monoclonal antibody which inhibits vWF binding to factor VIII.
    Piétu G, Ribba AS, Meulien P, Meyer D.
    Biochem Biophys Res Commun; 1989 Aug 30; 163(1):618-26. PubMed ID: 2476129
    [Abstract] [Full Text] [Related]

  • 14. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673.
    Christophe O, Obert B, Meyer D, Girma JP.
    Blood; 1991 Nov 01; 78(9):2310-7. PubMed ID: 1834252
    [Abstract] [Full Text] [Related]

  • 15. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
    Shima M, Scandella D, Yoshioka A, Nakai H, Tanaka I, Kamisue S, Terada S, Fukui H.
    Thromb Haemost; 1993 Mar 01; 69(3):240-6. PubMed ID: 7682339
    [Abstract] [Full Text] [Related]

  • 16. Autoantibody selectively inhibits binding of von Willebrand factor to glycoprotein ib. Recognition site is located in the A1 loop of von Willebrand factor.
    Mohri H, Yamazaki E, Suzuki Z, Takano T, Yokota S, Okubo T.
    Thromb Haemost; 1997 Apr 01; 77(4):760-6. PubMed ID: 9134656
    [Abstract] [Full Text] [Related]

  • 17. Comparison of tryptic fragments of von Willebrand factor involved in binding to thrombin-activated platelets with fragments involved in ristocetin-induced binding and binding to collagen.
    Houdijk WP, Girma JP, van Mourik JA, Sixma JJ, Meyer D.
    Thromb Haemost; 1986 Dec 15; 56(3):391-6. PubMed ID: 3551182
    [Abstract] [Full Text] [Related]

  • 18. Development of antibodies that interfere with the collagen-VWF-GPIb axis as new antithrombotics.
    Deckmyn H, Cauwenberghs N, Wu D, Depraetere H, Vanhoorelbeke K.
    Verh K Acad Geneeskd Belg; 2005 Dec 15; 67(1):55-65. PubMed ID: 15828307
    [Abstract] [Full Text] [Related]

  • 19. Primary binding domain of bovine von Willebrand factor fragment expressed in E. coli.
    Bakhshi MR, Sinha D, Vora RK, Budzynski AZ, Kirby EP.
    Thromb Haemost; 1996 Jan 15; 75(1):196-202. PubMed ID: 8713801
    [Abstract] [Full Text] [Related]

  • 20. Generation and characterization of specific antibodies directed to the binding domain of adhesive molecules.
    Berliner SA, Roberts JR, Thorn ML, Ruggeri ZM.
    Pept Res; 1988 Jan 15; 1(2):60-4. PubMed ID: 2485226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.